Repligen Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Repligen
RGEN Stock  USD 124.97  3.76  2.92%   
Repligen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Repligen's valuation are provided below:
Gross Profit
388.7 M
Profit Margin
0.0662
Market Capitalization
7 B
Enterprise Value Revenue
9.7163
Revenue
738.3 M
We have found one hundred twenty available trending fundamental ratios for Repligen, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to check out Repligen's recent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 2nd of March 2026, Market Cap is likely to grow to about 13.8 B. Also, Enterprise Value is likely to grow to about 13.5 B

Repligen Total Revenue

767.17 Million

Check Repligen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repligen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 46.2 M, Interest Expense of 24.3 M or Total Revenue of 767.2 M, as well as many indicators such as Price To Sales Ratio of 10.05, Dividend Yield of 0.0 or PTB Ratio of 2.92. Repligen financial statements analysis is a perfect complement when working with Repligen Valuation or Volatility modules.
  
Build AI portfolio with Repligen Stock
Check out the analysis of Repligen Correlation against competitors.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Repligen Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Short and Long Term Debt Total724.4 M689.9 M289.1 M
Slightly volatile
Other Current Liabilities88.5 M84.3 M32.4 M
Slightly volatile
Total Current Liabilities142.6 M135.8 M114.5 M
Slightly volatile
Property Plant And Equipment Net321.5 M306.2 M124.9 M
Slightly volatile
Cash594.3 M566 M339.6 M
Slightly volatile
Non Current Assets Total1.9 B1.8 B776.6 M
Slightly volatile
Non Currrent Assets Other3 M4.9 M1.3 M
Slightly volatile
Cash And Short Term Investments806 M767.6 M372.6 M
Slightly volatile
Net Receivables166.5 M158.6 M62.5 M
Slightly volatile
Common Stock Shares Outstanding31.4 M56.6 M41.2 M
Slightly volatile
Liabilities And Stockholders Equity3.1 B2.9 B1.3 B
Slightly volatile
Non Current Liabilities Total743.1 M707.7 M232.2 M
Slightly volatile
Inventory179 M170.5 M84.7 M
Slightly volatile
Other Current Assets42.7 M40.7 M14.3 M
Slightly volatile
Other Stockholder Equity1.7 B1.7 B854 M
Slightly volatile
Total Liabilities885.7 M843.6 M346.7 M
Slightly volatile
Property Plant And Equipment Gross598.4 M569.9 M183.5 M
Slightly volatile
Total Current Assets1.2 B1.1 B533.9 M
Slightly volatile
Accounts Payable31.5 M30 M14.7 M
Slightly volatile
Short Term Debt20.5 M21.6 M101 M
Very volatile
Intangible Assets405.5 M386.1 M185.1 M
Slightly volatile
Common Stock Total Equity389.2 K639.4 K434.3 K
Slightly volatile
Common Stock415.8 K563 K432.2 K
Slightly volatile
Property Plant Equipment230.2 M219.3 M82 M
Slightly volatile
Other Liabilities94.6 M90.1 M40.6 M
Slightly volatile
Current Deferred Revenue16 M15.2 M6.7 M
Slightly volatile
Good Will1.2 B1.1 B520.3 M
Slightly volatile
Net Tangible Assets847.1 M806.7 M387.8 M
Slightly volatile
Capital Surpluse1.9 B1.8 B885.4 M
Slightly volatile
Non Current Liabilities Other41.4 M41.7 M36 M
Slightly volatile
Deferred Long Term Asset Charges2.2 M2.9 M2.5 M
Pretty Stable
Long Term Debt Total156.7 M267.7 M165.9 M
Slightly volatile
Short and Long Term Debt75.9 M79.9 M128.9 M
Pretty Stable
Net Invested Capital1.9 B2.9 B1.4 B
Slightly volatile
Net Working Capital630.1 M1.1 B459.8 M
Slightly volatile
Capital Stock587.1 K645.1 K498.8 K
Slightly volatile
Capital Lease Obligations110.8 M184.8 M69.1 M
Slightly volatile

Repligen Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization46.2 M78.7 M102.6 M
Slightly volatile
Total Revenue767.2 M738.3 M1.7 B
Slightly volatile
Gross Profit528.3 M347.6 M1.2 B
Slightly volatile
Other Operating Expenses954.9 M678.7 M2.1 B
Slightly volatile
Cost Of Revenue238.8 M390.6 M533.2 M
Slightly volatile
Total Operating Expenses273.6 M288 M1.6 B
Slightly volatile
Research Development51.5 M54.2 M580.2 M
Slightly volatile
Selling General Administrative347.8 M237 M644.2 M
Slightly volatile
Net Income Applicable To Common Shares224.5 M213.9 M78 M
Slightly volatile
Interest Income4 M4.6 M2.8 M
Slightly volatile
Reconciled Depreciation104.5 M99.5 M34.9 M
Slightly volatile
Extraordinary Items7.7 M8.6 M9.4 M
Slightly volatile
Selling And Marketing Expenses504.8 K567.9 K619.9 K
Slightly volatile

Repligen Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow795.2 M757.4 M316.2 M
Slightly volatile
Depreciation101.8 M97 M32.1 M
Slightly volatile
Capital Expenditures30.3 M23.5 M58.5 M
Pretty Stable
End Period Cash Flow594.3 M566 M337.2 M
Slightly volatile
Stock Based Compensation48.7 M32.6 M17.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.0512.481411.9628
Slightly volatile
PTB Ratio2.924.37514.4969
Slightly volatile
Days Sales Outstanding46.9178.406863.1571
Pretty Stable
Average Payables2.6 M2.5 M2.5 M
Slightly volatile
Stock Based Compensation To Revenue0.0420.04420.2382
Slightly volatile
Capex To Depreciation0.230.24260.901
Very volatile
PB Ratio2.924.37514.4969
Slightly volatile
EV To Sales9.0112.649311.3614
Slightly volatile
Inventory Turnover3.212.29172.8534
Slightly volatile
Days Of Inventory On Hand134159171
Slightly volatile
Payables Turnover13.6713.016711.7763
Very volatile
Sales General And Administrative To Revenue0.370.390.318
Slightly volatile
Average Inventory14.4 M13.7 M12.8 M
Slightly volatile
Research And Ddevelopement To Revenue0.06970.07340.1858
Slightly volatile
Capex To Revenue0.03030.03190.0665
Very volatile
Cash Per Share14.3313.65067.3989
Slightly volatile
Days Payables Outstanding26.6428.040835.2601
Pretty Stable
Current Ratio9.468.37386.7452
Very volatile
Receivables Turnover4.424.65525.6115
Pretty Stable
Graham Number25.5824.3617.3199
Slightly volatile
Shareholders Equity Per Share39.3337.452918.9485
Slightly volatile
Debt To Equity0.340.32760.3511
Slightly volatile
Capex Per Share0.220.41820.4589
Slightly volatile
Graham Net Net1.352.28022.4681
Pretty Stable
Average Receivables8.1 M7.7 M8.1 M
Slightly volatile
Revenue Per Share13.7813.12836.5834
Slightly volatile
Interest Debt Per Share13.3212.68135.0359
Slightly volatile
Debt To Assets0.180.23390.3016
Pretty Stable
Operating Cycle154238233
Slightly volatile
Price Book Value Ratio2.924.37514.4969
Slightly volatile
Days Of Payables Outstanding26.6428.040835.2601
Pretty Stable
Ebt Per Ebit1.031.04710.8824
Pretty Stable
Long Term Debt To Capitalization0.250.24090.247
Pretty Stable
Total Debt To Capitalization0.260.24680.247
Pretty Stable
Debt Equity Ratio0.340.32760.3511
Slightly volatile
Quick Ratio8.487.11896.1176
Pretty Stable
Net Income Per E B T1.140.78381.0774
Pretty Stable
Cash Ratio5.814.16734.5105
Very volatile
Cash Conversion Cycle222210204
Slightly volatile
Days Of Inventory Outstanding134159171
Slightly volatile
Days Of Sales Outstanding46.9178.406863.1571
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.130.79970.7231
Slightly volatile
Price To Book Ratio2.924.37514.4969
Slightly volatile
Fixed Asset Turnover3.732.41144.2992
Slightly volatile
Debt Ratio0.180.23390.3016
Pretty Stable
Price Sales Ratio10.0512.481411.9628
Slightly volatile
Gross Profit Margin0.680.47090.5308
Pretty Stable
Price Fair Value2.924.37514.4969
Slightly volatile

Repligen Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap13.8 B13.1 B9.4 B
Slightly volatile
Enterprise Value13.5 B12.9 B9.3 B
Slightly volatile

Repligen Fundamental Market Drivers

Forward Price Earnings65.3595
Cash And Short Term Investments767.6 M

Repligen Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Repligen Financial Statements

Repligen investors utilize fundamental indicators, such as revenue or net income, to predict how Repligen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue15.2 M16 M
Total Revenue738.3 M767.2 M
Cost Of Revenue390.6 M238.8 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.39  0.37 
Research And Ddevelopement To Revenue 0.07  0.07 
Capex To Revenue 0.03  0.03 
Revenue Per Share 13.13  13.78 
Ebit Per Revenue 0.08  0.08 

Pair Trading with Repligen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Repligen Stock

  0.89A Agilent TechnologiesPairCorr
  0.88GSS Genetic SignaturesPairCorr

Moving against Repligen Stock

  0.76MLAB Mesa LaboratoriesPairCorr
  0.73CTE CryositePairCorr
  0.47OBD Oxford Biodynamics PLCPairCorr
The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.
The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:
How To Invest In Repligen
Details
Is Repligen Stock a good investment?
Details
What is Repligen's Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Repligen Correlation against competitors.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.6
Earnings Share
0.86
Revenue Per Share
13.128
Quarterly Revenue Growth
0.181
Return On Assets
0.0099
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY